Jeffrey Rousch

PhD, Arizona State University, Plant Biology (phycology) MS, Indiana University of Pennsylvania, Biology (aquatic toxicology) BS, Johnson State College, Environmental Chemistry BS, University of Hartford, Computer Science / Physics Joined Elizabeth City State University in Fall 2003. Prior to this, he was a postdoctoral research scientist at BASF Plant Science in the high plant oils group and also in the Plant Pathology Department at NC State University in a laboratory investigating the genetics, physiology and environmental conditions surrounding nematodes. He served as the Chair of the Department of Biology (now Natural Sciences) from 2008 - 2012 and continue to be active in the graduate program, undergraduate research activities, development of an alternative energy program and outreach activities. RESEARCH INTERESTS My laboratory is focused on investigating the ability of microphotosynthetic cells (algae) to remove aquatic pollutants from the environment and, conversely, how aquatic pollutants, like heavy metals, affect the growth and cellular physiology of these often overlooked organisms. This work is notable, not only from an environmental standpoint, but many of these organisms are capable of producing commercially important products, like antimicrobial compounds, therapeutics, product stabilizers and novel enzymes COURSES TAUGHT I teach a wide diversity of undergraduate and graduate courses in biology. Specifically, General Biology for Majors, Pollution Biology, Molecular Biology, Zoology, Principles of Biological Science, Career Entry Seminar, Independent Research, Advanced Biotechnology, Ethics in Biotechnology, Scientific Writing, Scientific Research and Communication, Bioinformatics, Introduction to Bioenergy and Field Experiences in Biology.

There are 2 included publications by Jeffrey Rousch :

TitleDateViewsBrief Description
Exploring the anti-cancer properties of novel Rhenium-based compounds 2021 63 Despite ongoing research, cancer remains a lethal disease claiming the lives of over 600,000 people in the US alone each year. While there are treatments available, many of them are toxic to healthy tissues in addition to the tumors they are designed...
A Study to Investigate the Role of Noncoding RNA miR146 Alpha as a Potential Biomarker in Prostate Cancer 2022 438 There is a need for additional biomarkers for the diagnosis and prognosis of prostate cancer. MicroRNAs are a class of non-protein coding RNA molecules that are frequently dysregulated in different cancers, including prostate cancer and show promise ...